ABRILADA
adalimumab-afzb · KIT · Pfizer Laboratories Div Pfizer Inc
No Recall History
Plain English
ABRILADA is a kit containing adalimumab-afzb. Manufactured by Pfizer Laboratories Div Pfizer Inc.
Key Facts
- Brand Name
- ABRILADA
- Generic Name
- adalimumab-afzb
- NDC Code (Product)
0025-0328- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA761118
- Marketing Start
- 12/14/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is ABRILADA used for?
ABRILADA contains adalimumab-afzb. It is a kit taken as directed. Consult your doctor for specific uses.
Is ABRILADA a controlled substance?
ABRILADA is not classified as a controlled substance by the DEA.
What is the generic name for ABRILADA?
The generic name for ABRILADA is adalimumab-afzb. There are no other listed brand versions of adalimumab-afzb.
What is the NDC code for ABRILADA ?
The NDC (National Drug Code) for ABRILADA is 0025-0328, listed by Pfizer Laboratories Div Pfizer Inc.
Other ABRILADA Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)